BioSpace News Archive

Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the first quarter ended March 31, 2019 on Monday, May 6, 2019.

Solera Health, an integrated benefits network, today announced the addition of four prominent business leaders to the company’s advisory board

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced that Drs. Paul Martin and Kevin Flanigan from the Research Institute at Nationwide Children’s Hospital have completed work under a $100,000 grant exploring GALGT2 gene therapy technology as a potential treatment for Duchenne.

A Lubbock, Texas-based company, Reproductive Solutions, Inc. (RSI), has introduced a new product, ProteX™, designed specifically for semen collection with the potential to improve fertility.

Nearly 93 percent of all consumers are more likely to be loyal to a brand when it commits to full transparency, according to a 2017 Label Insights study from the Food Marketing Institute

ExplORer Surgical, a leading platform for intraoperative surgical and interventional procedure workflow management and analytics, announced today the closing of a new $5M financing round.

Through increased efforts to better manage opioid use, and encourage more appropriate therapies generally, myMatrixx helped workers’ compensation plans reduce drug spending by 3.8% in 2018, according to the annual myMatrixx Drug Trend Report released today.

As an Ebola outbreak rages on in the Congo with the highest mortality rate in history, AHF urges the World Health Organization (WHO) to expedite approval of a proven vaccine and declare an international emergency

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, today commented on a grossly misleading article published yesterday by an anonymous self-professed short seller of the Company’s stock.

Steven Gurien, MD, a Northwell Health surgical resident and member of The Feinstein Institute for Medical Research, was honored by the Society of Critical Care Medicine (SCCM) with its Star Research Achievement Award for his efforts to pinpoint specific molecules that can reduce inflammation during sepsis.